// App-Quantinova.ai

: IMMUNOLOGICAL RECONSTITUTION AND PLATELET DISFUNCTION DURING IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Researchers

Presenter

  • Idanna Innocenti

Principal Investigators

  • Francesco Autore

  • Maria Adele Alberelli

  • Raffaella Pasquale

  • Andrea Corbingi

  • Beatrice Di Giacomo

  • Silvia Bellesi

  • Francesco Corrente

  • Simona Sica

  • Erica De Candia

  • Luca Laurenti

Medical Centers

  • Department of Hematology, Catholic University of Sacred Heart, Rome/ Institute of Hematology,Rome,Italy

  • Department of Oncology and Hematology,Catholic University of Sacred Heart,Rome,Italy

  • Department of Hematology,Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan,Milan,Italy

  • Department of Hematology, Catholic University of Sacred Heart, Rome/ Institute of Hematology,Rome,Italy

  • Department of Oncology and Hematology,Catholic University of Sacred Heart,Rome,Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 79A

  • Cluster of differentiation 8A

  • Fc gamma RIIIa

  • Immunoglobulin G

  • Tumor protein p53

Drug/Treatment

  • Ibrutinib

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved